The Department of Justice filed a civil action Tuesday against Walmart for playing an active role in fueling the opioid epidemic, a lawsuit Walmart calls “misguided.”
The complaint, filed in the U.S. District Court for the District of Delaware, alleges “hundreds of thousands” of violations of the Controlled Substances Act (CSA), which regulates supply chain participants—from manufacturers to wholesale distributors to retail pharmacies—who handle controlled substances. Under the CSA, suppliers are responsible for preventing the misuse of controlled substances, including prescription opioids.
